BioCentury
ARTICLE | Company News

Stellar Pharmaceuticals, Theramed Corp. sales and marketing update

June 25, 2012 7:00 AM UTC

Stellar received exclusive, Canadian rights from Theramed to Collatamp G, which is approved for local hemostasis of capillary, parenchymatous and seeping hemorrhages in areas with a high risk of infection. Collatamp is a lyophilized collagen implant containing gentamicin, an aminoglycoside antibiotic. Details were not disclosed. ...